No abstract available
Keywords:
Cardiovascular risk; Exercise; Insulin resistance; Spondyloarthritis; TNF inhibitors.
MeSH terms
-
Adalimumab / therapeutic use
-
Adult
-
Antirheumatic Agents / therapeutic use*
-
Biomarkers / blood
-
Etanercept / therapeutic use
-
Exercise / physiology*
-
Female
-
Humans
-
Infliximab / therapeutic use
-
Lactic Acid / biosynthesis*
-
Lactic Acid / blood
-
Male
-
Middle Aged
-
Muscle, Skeletal / drug effects
-
Muscle, Skeletal / metabolism*
-
Muscle, Skeletal / physiopathology
-
Randomized Controlled Trials as Topic
-
Spondylarthritis / blood*
-
Spondylarthritis / drug therapy
-
Spondylarthritis / physiopathology
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Substances
-
Antirheumatic Agents
-
Biomarkers
-
Tumor Necrosis Factor-alpha
-
Lactic Acid
-
Infliximab
-
Adalimumab
-
Etanercept